Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group study (Q50532012)
Jump to navigation
Jump to search
scientific article published in January 1993
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group study |
scientific article published in January 1993 |
Statements
Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group study (English)
1 reference
Alberts DS
1 reference
Surwit EA
1 reference
Dahlberg S
1 reference
Green SJ
1 reference
Garcia D
1 reference
Hannigan EV
1 reference
O'Toole R
1 reference
Stock-Novack D
1 reference
Malviya VK
1 reference
Jolles CJ
1 reference
1 January 1993
1 reference
1 reference
71
1 reference
2 Suppl
1 reference
618-627
1 reference